Literature DB >> 35674963

The Use of Galleria mellonella Larvae to Study the Pathogenicity and Clonal Lineage-Specific Behaviors of the Emerging Fungal Pathogen Candida auris.

Andrew M Borman1,2.   

Abstract

Candida species are the most common fungal causes of disseminated infections in humans. Although such infections are associated with high morbidity and mortality, it is widely accepted that virulence, antifungal susceptibility, and disease outcome vary according to individual Candida species. In this respect, the emerging pathogen Candida auris has received much attention due to its propensity to cause widespread nosocomial outbreaks, to exhibit high virulence in several infection models, and to develop resistance to multiple classes of antifungal drugs. Although mammalian models of infection have long been viewed as the gold standard for studies on fungal virulence, comparative pathogenicity, and evaluation of antifungal drug efficacy, the larvae of the greater wax moth Galleria mellonella have shown considerable promise as an alternative invertebrate model of infection. Galleria larvae are inexpensive, are easily maintained in the laboratory, tolerate incubation at human physiological temperatures, possess cellular and humoral immune systems that share many features with mammals, and allow investigation of pathogenicity/virulence using multiple different reading endpoints. Here, I describe in detail the methods that can be used to study the virulence/pathogenicity of Candida auris in G. mellonella.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Candida auris; Clades; Clonal lineages; Galleria mellonella; Pathogenesis; Virulence

Mesh:

Substances:

Year:  2022        PMID: 35674963     DOI: 10.1007/978-1-0716-2417-3_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  28 in total

Review 1.  Candida auris: a Review of the Literature.

Authors:  Anna Jeffery-Smith; Surabhi K Taori; Silke Schelenz; Katie Jeffery; Elizabeth M Johnson; Andrew Borman; Rohini Manuel; Colin S Brown
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

2.  Multidrug-resistant endemic clonal strain of Candida auris in India.

Authors:  A Chowdhary; V Anil Kumar; C Sharma; A Prakash; K Agarwal; R Babu; K R Dinesh; S Karim; S K Singh; F Hagen; J F Meis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-20       Impact factor: 3.267

3.  Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.

Authors:  Shawn R Lockhart; Kizee A Etienne; Snigdha Vallabhaneni; Joveria Farooqi; Anuradha Chowdhary; Nelesh P Govender; Arnaldo Lopes Colombo; Belinda Calvo; Christina A Cuomo; Christopher A Desjardins; Elizabeth L Berkow; Mariana Castanheira; Rindidzani E Magobo; Kauser Jabeen; Rana J Asghar; Jacques F Meis; Brendan Jackson; Tom Chiller; Anastasia P Litvintseva
Journal:  Clin Infect Dis       Date:  2016-10-20       Impact factor: 9.079

Review 4.  The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris.

Authors:  Guillermo Quindós; Cristina Marcos-Arias; Rosario San-Millán; Estibaliz Mateo; Elena Eraso
Journal:  Int Microbiol       Date:  2018-07-06       Impact factor: 2.479

5.  Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.

Authors:  Kazuo Satoh; Koichi Makimura; Yayoi Hasumi; Yayoi Nishiyama; Katsuhisa Uchida; Hideyo Yamaguchi
Journal:  Microbiol Immunol       Date:  2009-01       Impact factor: 1.955

Review 6.  Invasive candidiasis.

Authors:  Peter G Pappas; Michail S Lionakis; Maiken Cavling Arendrup; Luis Ostrosky-Zeichner; Bart Jan Kullberg
Journal:  Nat Rev Dis Primers       Date:  2018-05-11       Impact factor: 52.329

Review 7.  Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris.

Authors:  Andrea Cortegiani; Giovanni Misseri; Teresa Fasciana; Anna Giammanco; Antonino Giarratano; Anuradha Chowdhary
Journal:  J Intensive Care       Date:  2018-10-29

8.  Potential Fifth Clade of Candida auris, Iran, 2018.

Authors:  Nancy A Chow; Theun de Groot; Hamid Badali; Mahdi Abastabar; Tom M Chiller; Jacques F Meis
Journal:  Emerg Infect Dis       Date:  2019-09-17       Impact factor: 6.883

9.  Candida auris-associated candidemia, South Africa.

Authors:  Rindidzani E Magobo; Craig Corcoran; Sharona Seetharam; Nelesh P Govender
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

10.  Candida auris in the UK: Introduction, dissemination, and control.

Authors:  Andrew M Borman; Elizabeth M Johnson
Journal:  PLoS Pathog       Date:  2020-07-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.